TY  - GEN
AU  - Hui,Lucy
AU  - von Keudell,Gottfried
AU  - Wang,Rong
AU  - Zeidan,Amer M
AU  - Gore,Steven D
AU  - Ma,Xiaomei
AU  - Davidoff,Amy J
AU  - Huntington,Scott F
TI  - Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation
SN  - 1097-0142
PY  - 2017///0927
KW  - Adult
KW  - Autografts
KW  - Brentuximab Vedotin
KW  - Consolidation Chemotherapy
KW  - economics
KW  - Cost-Benefit Analysis
KW  - Disease Progression
KW  - Health Care Costs
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Immunoconjugates
KW  - therapeutic use
KW  - Markov Chains
KW  - Middle Aged
KW  - Quality of Life
KW  - Quality-Adjusted Life Years
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1002/cncr.30818
ER  -